Boston Partners Has $24.77 Million Position in Teleflex Incorporated (NYSE:TFX)

Key Points

• Boston Partners increased its stake in Teleflex by 21.1%, owning 179,281 shares valued at approximately $24.77 million as of the latest SEC filing.
• Teleflex recently reported earnings of $3.73 EPS for the quarter, exceeding analysts' expectations, with a revenue of $780.90 million, up 4.2% year-over-year.
• The company announced a quarterly dividend of $0.34 per share, representing an annualized yield of 1.1%, with a payout ratio of 32%.

Boston Partners lifted its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 21.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 179,281 shares of the medical technology company's stock after purchasing an additional 31,239 shares during the quarter. Boston Partners owned 0.41% of Teleflex worth $24,772,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in TFX. Sterling Capital Management LLC grew its holdings in shares of Teleflex by 55.5% during the 4th quarter. Sterling Capital Management LLC now owns 2,791 shares of the medical technology company's stock valued at $497,000 after purchasing an additional 996 shares during the last quarter. Barclays PLC grew its holdings in shares of Teleflex by 20.9% during the 4th quarter. Barclays PLC now owns 108,689 shares of the medical technology company's stock valued at $19,344,000 after purchasing an additional 18,782 shares during the last quarter. Mariner LLC grew its holdings in shares of Teleflex by 7.9% during the 4th quarter. Mariner LLC now owns 5,430 shares of the medical technology company's stock valued at $966,000 after purchasing an additional 396 shares during the last quarter. Walleye Capital LLC grew its holdings in shares of Teleflex by 420.2% during the 4th quarter. Walleye Capital LLC now owns 6,695 shares of the medical technology company's stock valued at $1,192,000 after purchasing an additional 5,408 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan bought a new stake in shares of Teleflex during the 4th quarter valued at approximately $68,000. 95.62% of the stock is owned by institutional investors.

Teleflex Trading Down 1.0%

NYSE:TFX opened at $121.68 on Friday. The firm's fifty day moving average is $117.97 and its 200-day moving average is $133.22. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. Teleflex Incorporated has a 52 week low of $108.90 and a 52 week high of $249.90. The firm has a market cap of $5.38 billion, a P/E ratio of 28.63, a P/E/G ratio of 1.71 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. During the same quarter in the previous year, the company earned $3.42 EPS. Teleflex's quarterly revenue was up 4.2% compared to the same quarter last year. Equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, August 15th. Teleflex's payout ratio is presently 32.00%.

Insider Activity at Teleflex

In related news, CEO Liam Kelly bought 1,500 shares of the company's stock in a transaction that occurred on Tuesday, August 5th. The shares were bought at an average price of $115.07 per share, for a total transaction of $172,605.00. Following the transaction, the chief executive officer directly owned 45,267 shares of the company's stock, valued at approximately $5,208,873.69. The trade was a 3.43% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jaewon Ryu bought 1,500 shares of the company's stock in a transaction that occurred on Tuesday, August 5th. The shares were bought at an average price of $115.00 per share, for a total transaction of $172,500.00. Following the transaction, the director directly owned 3,727 shares in the company, valued at $428,605. This trade represents a 67.36% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 5,500 shares of company stock worth $633,590 over the last ninety days. 1.40% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Truist Financial decreased their price target on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. Mizuho boosted their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a report on Friday, August 1st. Morgan Stanley reduced their target price on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Monday, May 5th. Royal Bank Of Canada boosted their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a report on Friday, August 1st. Finally, Wells Fargo & Company reduced their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. One analyst has rated the stock with a sell rating, eight have given a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Teleflex presently has a consensus rating of "Hold" and an average price target of $141.57.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.